TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.80
−2.68%Leverage
- Debt / equity
- 8.91x
- Net debt / equity
- -6.07x
- Debt / assets
- 0.36x
- Debt / EBITDA
- -1.47x
- Net debt / EBITDA
- 1.00x
Liquidity & coverage
- Current ratio
- 1.19x
- Quick ratio
- 1.19x
- Cash ratio
- 1.17x
- Interest coverage
- -28.93x
- EBITDA / interest
- -17.27x
- Working capital
- $1.7M
Cash & dividend
- FCF / debt
- -0.71x
- Cash flow / debt
- -0.71x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026